ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Stoke Therapeutics Inc

Stoke Therapeutics Inc (STOK)

16.25
-1.27
(-7.25%)
Closed June 16 4:00PM
16.25
-0.01
(-0.06%)
After Hours: 4:00PM

Stoke Therapeutics Inc Financial Summary

The current STOK market cap is 725.62M. The company's latest EPS is USD -2.3447 and P/E is -6.93.

Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 5.15M-2.48M3.31M2.8M4.22M
Operating Income -24.69M-33.26M-27.23M-29.59M-28.37M
Net Income -22.55M-30.65M-24.54M-26.96M-26.37M
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 00012.41M8.78M
Operating Income -35.68M-53.04M-86.07M-104.36M-114.77M
Net Income -32.33M-52.24M-85.81M-101.07M-104.7M
Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 281.8M256.92M239.89M228.34M205.18M
Total Liabilities 67.97M66.72M66.89M68.78M64.84M
Total Equity 213.82M190.2M173M159.57M140.34M
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 228.75M297.93M238.87M256.07M228.34M
Total Liabilities 4.32M11.85M21.09M71.22M68.78M
Total Equity 224.43M286.08M217.78M184.85M159.57M
Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
USD ($)USD ($)USD ($)USD ($)USD ($)
Operating -21.36M-43.16M-60.42M-81.07M-24.57M
Investing 53.09M76.56M91.18M105.95M9.99M
Financing 45.05M45.1M45.66M53.01M1.72M
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Operating -31.06M-42.22M-66.91M-31.87M-81.07M
Investing -1.63M-1.05M-76.43M-45.88M105.95M
Financing 149.76M108.11M1.28M46.41M53.01M
Market Cap 725.62M
Price to Earnings Ratio -6.93
Price to Sales Ratio 82.71
Price to Cash Ratio 3.79
Price to Book Ratio 4.55
Dividend Yield -

Share Statistics

Shares Outstanding 44.65M
Average Volume (1 week) 659.46k
Average Volume (1 Month) 735.51k
52 Week Change 30.21%
52 Week High 17.58
52 Week Low 3.35
Spread (Intraday) 4.8 (27.33%)

Company Info

Company Name Stoke Therapeutics Inc
Address 3500 s dupont hwy
dover, delaware 19901
Website https://www.stoketherapeutics.com
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock